Pure Global

HbA1c - India CDSCO Medical Device Registration

HbA1c is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000048_f0db786141f00b78e5b1a8873c63a7ff_da3cc13ee02f0ed283ee526731a76598. This device is marketed under the brand name NycoCardโ„ข HbA1c. The license holder is Abbott Diagnostics Medical Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
HbA1c
UID: IMP/IVD/2020/000048_f0db786141f00b78e5b1a8873c63a7ff_da3cc13ee02f0ed283ee526731a76598

Brand Name

NycoCardโ„ข HbA1c

Device Class

Class B

Approving Authority

CDSCO

Product Information

Afinionโ„ข HbA1c is an in vitro diagnostic test for quantitative determination of glycated hemoglobin (NycoCardโ„ข HbA1c) in human whole blood

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing